Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angelo Porreca

Showing results (151-160 of 193) with videos related to

Pageof 20
Sort By:
Cancers|April 13, 2024
Open versus Robot-Assisted Radical Cystectomy for the Treatment of pT4a Bladder Cancer: Comparison of Perioperative OutcomesDavide Perri, Bernardo Rocco, Maria Chiara Sighinolfi, et al.
Aging Clinical and Experimental Research|February 26, 2017
Pros-IT CNR: an Italian prostate cancer monitoring projectMarianna Noale, Stefania Maggi, Walter Artibani, et al.
Plos One|November 2, 2019
Treatment paths for localised prostate cancer in Italy: The results of a multidisciplinary, observational, prospective study (Pros-IT CNR)Michela Buglione, Marianna Noale, Alessio Bruni, et al.
World Journal of Urology|April 21, 2023
The role of warm ischemia time on functional outcomes after robotic partial nephrectomy: a radionuclide renal scan study from the clock randomized trialAlessan Dro Antonelli, Luca Cindolo, Marco Sandri, et al.
European Urology Oncology|February 7, 2026
Second Transurethral Resection of Bladder Tumor Can Be Safely Omitted in Selected Patients with T1 Non-muscle-invasive Bladder Cancer: Results from the Prospective HuNIRe TrialRoberto Contieri, Marco Paciotti, Alessandro Uleri, et al.
Diagnostics (Basel, Switzerland)|March 6, 2021
Assessment of PSIM (Prostatic Systemic Inflammatory Markers) Score in Predicting Pathologic Features at Robotic Radical Prostatectomy in Patients with Low-Risk Prostate Cancer Who Met the Inclusion Criteria for Active SurveillanceMatteo Ferro, Gennaro Musi, Deliu Victor Matei, et al.
Cancers|April 30, 2021
SelectMDx and Multiparametric Magnetic Resonance Imaging of the Prostate for Men Undergoing Primary Prostate Biopsy: A Prospective Assessment in a Multi-Institutional StudyMartina Maggi, Francesco Del Giudice, Ugo G Falagario, et al.
Minerva Urology and Nephrology|January 13, 2021
Health-related quality of life 24 months after prostate cancer diagnosis: an update from the Pros-IT CNR prospective observational studyCarlotta Palumbo, Alessio Bruni, Alessandro Antonelli, et al.
Urologia Internationalis|June 24, 2021
Increased Body Mass Index Is a Risk Factor for Poor Clinical Outcomes after Radical Prostatectomy in Men with International Society of Urological Pathology Grade Group 1 Prostate Cancer Diagnosed with Systematic BiopsiesMatteo Ferro, Daniela Terracciano, Gennaro Musi, et al.
European Urology Oncology|January 25, 2026
Real-World Burden and Management of Late Genitourinary Toxicity After Prostate Radiotherapy: Insights from IRRADIaTE, the Italian Registry of Radiotherapy-Associated Disorders and Urological Treatment & EvaluationRiccardo Bertolo, Antonio Luigi Pastore, Paolo Verze, et al.
Pageof 20

Showing results (151-160 of 193) with videos related to

Sort By:
Pageof 20
Cancers|April 13, 2024
Open versus Robot-Assisted Radical Cystectomy for the Treatment of pT4a Bladder Cancer: Comparison of Perioperative OutcomesDavide Perri, Bernardo Rocco, Maria Chiara Sighinolfi, et al.
Aging Clinical and Experimental Research|February 26, 2017
Pros-IT CNR: an Italian prostate cancer monitoring projectMarianna Noale, Stefania Maggi, Walter Artibani, et al.
Plos One|November 2, 2019
Treatment paths for localised prostate cancer in Italy: The results of a multidisciplinary, observational, prospective study (Pros-IT CNR)Michela Buglione, Marianna Noale, Alessio Bruni, et al.
World Journal of Urology|April 21, 2023
The role of warm ischemia time on functional outcomes after robotic partial nephrectomy: a radionuclide renal scan study from the clock randomized trialAlessan Dro Antonelli, Luca Cindolo, Marco Sandri, et al.
European Urology Oncology|February 7, 2026
Second Transurethral Resection of Bladder Tumor Can Be Safely Omitted in Selected Patients with T1 Non-muscle-invasive Bladder Cancer: Results from the Prospective HuNIRe TrialRoberto Contieri, Marco Paciotti, Alessandro Uleri, et al.
Diagnostics (Basel, Switzerland)|March 6, 2021
Assessment of PSIM (Prostatic Systemic Inflammatory Markers) Score in Predicting Pathologic Features at Robotic Radical Prostatectomy in Patients with Low-Risk Prostate Cancer Who Met the Inclusion Criteria for Active SurveillanceMatteo Ferro, Gennaro Musi, Deliu Victor Matei, et al.
Cancers|April 30, 2021
SelectMDx and Multiparametric Magnetic Resonance Imaging of the Prostate for Men Undergoing Primary Prostate Biopsy: A Prospective Assessment in a Multi-Institutional StudyMartina Maggi, Francesco Del Giudice, Ugo G Falagario, et al.
Minerva Urology and Nephrology|January 13, 2021
Health-related quality of life 24 months after prostate cancer diagnosis: an update from the Pros-IT CNR prospective observational studyCarlotta Palumbo, Alessio Bruni, Alessandro Antonelli, et al.
Urologia Internationalis|June 24, 2021
Increased Body Mass Index Is a Risk Factor for Poor Clinical Outcomes after Radical Prostatectomy in Men with International Society of Urological Pathology Grade Group 1 Prostate Cancer Diagnosed with Systematic BiopsiesMatteo Ferro, Daniela Terracciano, Gennaro Musi, et al.
European Urology Oncology|January 25, 2026
Real-World Burden and Management of Late Genitourinary Toxicity After Prostate Radiotherapy: Insights from IRRADIaTE, the Italian Registry of Radiotherapy-Associated Disorders and Urological Treatment & EvaluationRiccardo Bertolo, Antonio Luigi Pastore, Paolo Verze, et al.
Pageof 20